Fred Chang's lab at UCSF focuses on understanding how the crowded environment inside cells affects their growth and division. They study how physical forces from molecules in the cytoplasm influence cellular processes like microtubule dynamics and chromosome movement. This research is important for understanding basic cell biology and has implications for diseases such as cancer and aging.

Dr. Sophie Dumont's lab at UCSF studies how chromosomes are accurately segregated during cell division, a crucial process for cell health. They explore the physical and molecular mechanisms behind this process, particularly focusing on the spindle and kinetochore structures that help move chromosomes. Through innovative techniques like microneedle manipulation and live cell imaging, the lab aims to understand the fundamental principles of chromosome segregation, which has important implications for understanding cancer and congenital abnormalities.

Dr. Saul A. Villeda's lab at UCSF focuses on understanding how factors in our blood can help improve cognitive function and regeneration in the aging brain. They study how exercise influences these blood factors and also explore potential therapies for age-related diseases like Alzheimer's. The ultimate goal is to identify ways to reverse cognitive decline and enhance brain function in older adults.

Dr. Walter Patrick Devine's lab at UCSF focuses on improving clinical testing methods for patients with advanced cancers, particularly those suffering from malignant pleural effusions (MPEs). The research aims to optimize the analysis of cell-free DNA found in the fluid collected during thoracentesis, which is often the only specimen available for diagnosing cancer. By developing standardized protocols for processing this DNA, the team hopes to enhance testing accuracy and efficiency, ultimately benefiting patient care.

Dr. Matthew Krummel's lab at UCSF focuses on understanding how the immune system distinguishes between self and foreign cells. Through innovative research on immune cells like T cells and dendritic cells, the lab aims to improve treatments for cancer and autoimmune diseases. They explore specific cellular mechanisms that could enhance the effectiveness of immunotherapies, ultimately aiming to boost the body's ability to fight tumors while minimizing autoimmunity.

Dr. Ari B. Molofsky's lab at UCSF focuses on understanding the immune system's responses to allergens and brain injuries. The research primarily investigates how certain immune cells, called type 2 lymphocytes, function and localize within tissues during inflammation. The lab also explores the role of fibroblast cells in the brain and how they interact with the immune system to influence recovery from injury. The findings aim to inform future therapies for allergic diseases and neuroinflammatory conditions.

Dr. Stephen L. Nishimura's lab at UCSF focuses on understanding how the transforming growth factor-beta (TGF-β) cytokine regulates fibrosis and inflammation in the lungs. Their research aims to uncover the molecular mechanisms of TGF-β activation to develop more targeted and effective therapies for lung diseases like pulmonary fibrosis, which currently have few treatment options.

Dr. Eric J Huang’s lab at the University of California, San Francisco, focuses on understanding how defects in autophagy and endolysosomal trafficking contribute to neurodegenerative diseases, especially Frontotemporal Dementia (FTD). By studying the roles of microglia and their interactions with neurons, the lab investigates how these cellular processes may lead to neuronal loss and disease progression. The research combines molecular biology techniques with advanced proteomics to uncover new pathways that could lead to therapeutic targets for neurodegeneration.

Dr. Jeffrey Ohmann Bush's research lab at UCSF focuses on understanding how the cells shape the craniofacial structure during development and what goes wrong in craniofacial congenital anomalies. Using innovative techniques, including live imaging and CRISPR, the lab investigates the cellular behaviors and signaling mechanisms that lead to these birth defects. The goal is to translate this knowledge into improved therapeutic strategies for treating craniofacial conditions.

Dr. Rushika Perera's lab at UCSF focuses on understanding pancreatic cancer, specifically the mechanisms that allow these cancer cells to survive in harsh environments. The lab explores how certain proteins in lysosomes, which are the cell's waste disposal units, help pancreatic cancer cells grow and spread, even in nutrient-poor conditions. By investigating these processes, the lab aims to develop new treatment strategies targeting these proteins to combat this aggressive cancer.

Dr. Aleksandar Rajkovic's lab at UCSF focuses on improving access to genomic healthcare, especially for underserved communities. They are implementing an innovative electronic consultation network called WestGEN, which connects healthcare providers with genetic specialists. This project not only enhances provider training in genomics but also explores the use of artificial intelligence to streamline these consultations, ultimately aiming to improve patient outcomes and health equity.

Dr. Jeroen Roose's lab at UCSF focuses on understanding how T cell receptors (TCR) signal within the immune system. They study the unique mechanisms by which T cells can differentiate between self and non-self, ensuring appropriate immune responses. The lab employs a range of techniques from structural biology to computational biology to explore how TCR signaling pathways are organized and regulated.

Dr. Matthew D Stachler's lab at UCSF focuses on understanding how Barrett's esophagus, a condition that can lead to esophageal cancer, progresses and how at-risk patients can be identified. The team develops and validates a combination of genomic and methylation biomarkers to enhance risk stratification for patients. Through this research, they aim to improve early detection and treatment of esophageal adenocarcinoma, which is often aggressive and difficult to manage.

Dr. Arun P. Wiita's lab at UCSF focuses on developing innovative therapies for acute myeloid leukemia (AML), a challenging blood cancer. Their research combines proteomics and immunotherapy techniques to identify and exploit unique surface proteins on cancer cells, aiming to create targeted treatments that are both effective and less toxic than existing options. The lab's recent work on radioimmunotherapy is poised to significantly improve patient outcomes in AML.

Dr. Julie Beth Sneddon's lab at UCSF focuses on understanding how human pancreatic cells develop, specifically the beta cells that produce insulin. By studying the unique aspects of human cell development, especially through new techniques like single-cell multi-omics, the lab aims to enhance methods for creating these insulin-producing cells from stem cells. This research is vital for developing effective treatments for diabetes, a disease that affects millions worldwide.

Dr. Adrian Erlebacher's lab at UCSF focuses on understanding how the fetus and placenta evade rejection by the maternal immune system. They investigate the role of glycosylated proteins on the surface of the placenta in modulating immune responses, which has implications for pregnancy complications like preeclampsia and miscarriage. Their research combines animal models and human samples to explore these mechanisms and aims to open new avenues for developing immune tolerance therapies.